Tap Consulting, LLC Bolt Biotherapeutics, Inc. Transaction History
Tap Consulting, LLC
- $446 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding BOLT
# of Institutions
40Shares Held
24.3MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA3.52MShares$2.54 Million0.66% of portfolio
-
Tang Capital Management LLC San Diego, CA3.42MShares$2.46 Million0.58% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.75MShares$1.98 Million0.22% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.42MShares$1.74 Million0.0% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA1.89MShares$1.36 Million1.94% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $27.1M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...